SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-019116
Filing Date
2021-08-10
Accepted
2021-08-10 09:20:32
Documents
61
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 form10q.htm   iXBRL 10-Q 869625
2 ex31-1.htm EX-31.1 19209
3 ex31-2.htm EX-31.2 17842
4 ex32-1.htm EX-32.1 7901
  Complete submission text file 0001493152-21-019116.txt   4538535

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE pulm-20210630.xsd EX-101.SCH 38499
6 XBRL CALCULATION FILE pulm-20210630_cal.xml EX-101.CAL 48894
7 XBRL DEFINITION FILE pulm-20210630_def.xml EX-101.DEF 135161
8 XBRL LABEL FILE pulm-20210630_lab.xml EX-101.LAB 314218
9 XBRL PRESENTATION FILE pulm-20210630_pre.xml EX-101.PRE 227967
10 EXTRACTED XBRL INSTANCE DOCUMENT form10q_htm.xml XML 742415
Mailing Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421 (781) 357-2333
Pulmatrix, Inc. (Filer) CIK: 0001574235 (see all company filings)

IRS No.: 461821392 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36199 | Film No.: 211158651
SIC: 2834 Pharmaceutical Preparations